PABLO
MARTINEZ CAMBLOR
Investigador/a
Instituto Universitario de Oncologia del Principado de Asturias
Oviedo, EspañaPublicaciones en colaboración con investigadores/as de Instituto Universitario de Oncologia del Principado de Asturias (22)
2024
2023
-
Statistical Considerations for Analyzing Data Derived from Long Longitudinal Cohort Studies
Mathematics, Vol. 11, Núm. 19
-
Tracking between cardiovascular-related measures at 4 and 8 years of age in the INMA-Asturias cohort
European Journal of Pediatrics, Vol. 182, Núm. 9, pp. 3893-3906
2022
-
Arsenic exposure and respiratory outcomes during childhood in the INMA study
PLoS ONE, Vol. 17, Núm. 9 September
2021
-
Resistance and Endurance Exercise Training Induce Differential Changes in Gut Microbiota Composition in Murine Models
Frontiers in Physiology, Vol. 12
2019
-
Lectin-like transcript 1 (LLT1) expression is associated with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma
Archives of Dermatological Research, Vol. 311, Núm. 5, pp. 369-376
-
Liberal red blood cell transfusions impair quality of life after cardiac surgery
Medicina Intensiva, Vol. 43, Núm. 3, pp. 156-164
-
Traditional Processed Meat Products Re-designed Towards Inulin-rich Functional Foods Reduce Polyps in Two Colorectal Cancer Animal Models
Scientific Reports, Vol. 9, Núm. 1
2018
-
Reply to: “Prognostic significance of tumor budding in cutaneous squamous cell carcinoma”
Journal of the American Academy of Dermatology
2017
-
Cisplatin resistance in cell models evaluation of metallomic and biological predictive biomarkers to address early therapy failure
Metallomics, Vol. 9, Núm. 5, pp. 564-574
-
The adverse prognostic effect of tumor budding on the evolution of cutaneous head and neck squamous cell carcinoma
Journal of the American Academy of Dermatology, Vol. 76, Núm. 6, pp. 1139-1145
-
Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neck
Journal of the American Academy of Dermatology, Vol. 77, Núm. 3, pp. 527-533
2016
-
Cumulative/dynamic ROC curve estimation
Journal of Statistical Computation and Simulation, Vol. 86, Núm. 17, pp. 3582-3594
-
Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas
Oncotarget, Vol. 7, Núm. 20, pp. 29780-29793
2015
-
H3K4me1 marks DNA regions hypomethylated during aging in human stem and differentiated cells
Genome Research, Vol. 25, Núm. 1, pp. 27-40
2013
-
A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma
Journal of Molecular Medicine, Vol. 91, Núm. 8, pp. 939-950
-
DNA Methylation Dynamics in Blood after Hematopoietic Cell Transplant
PLoS ONE, Vol. 8, Núm. 2
-
DNA methylation signatures identify biologically distinct thyroid cancer subtypes
Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 7, pp. 2811-2821
-
Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors
Cancer Research, Vol. 73, Núm. 1, pp. 395-405
-
Long-term biomonitoring of breast cancer patients under adjuvant chemotherapy: the comet assay as a possible predictiv
Mutagenesis, Vol. 28, Núm. 1, pp. 39-48